EssilorLuxottica Société anonyme against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-09-23T15:36:14+00:00 UTC · updates daily
TEVA leads 3 of the 5 windows we measure — over 1 month EL.PA is -7.3% and TEVA +5.6%; over year to date EL.PA is -44.4% and TEVA +25.0%.
| EL.PA | TEVA | |
|---|---|---|
| Price | $149.95 | $39.01 |
| 1 day | +3.8%lead | -1.3% |
| 5 days | +3.3%lead | +1.2% |
| 1 month | -7.3% | +5.6%lead |
| 6 months | -22.3% | +35.6%lead |
| Year to date | -44.4% | +25.0%lead |
| 52-week position | 6% of range | 92% of range |
| 52-week range | $138.30–$323.80 | $18.21–$40.79 |
| vs 50-day average | below $159.21 | above $35.79 |
| vs 200-day average | below $199.87 | above $33.32 |
| RSI (14) | 45 | 59 |
| Next earnings | 2026-02-11 | 2026-11-03 |
EL.PA trades at $149.95, below its 50-day average of $159.21, and below the 200-day at $199.87. It sits at 6% of its 52-week range ($138.30–$323.80); 14-day RSI is 45, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $150.00 (0.0% away) and the first support below is $139.00 (7.3% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
TEVA trades at $39.01, above its 50-day average of $35.79, and above the 200-day at $33.32. It sits at 92% of its 52-week range ($18.21–$40.79); 14-day RSI is 59, in neutral territory; an average session moves it about 3.3%. For levels, the first level overhead is $40.00 (2.5% away) and the first support below is $35.79 (8.2% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA is the more volatile of the two — an average session moves it 3.3% against 2.6% for EL.PA, so an identical position size carries roughly 1.3× the daily risk.
The comparison turns on those levels: EL.PA clearing $150.00 or losing $139.00; TEVA clearing $40.00 or losing $35.79. Until one of them gives way, the relative reading above stands.